Terms: = Breast cancer AND SMAD3, JV15-2, 4088, ENSG00000166949, P84022, Smad3, MADH3, HsT17436, Smad 3, DKFZp686J10186, HSPC193, DKFZP586N0721, MGC60396 AND Treatment
80 results:
1. In-silico and in-vitro evidence suggest LINC01405 as a sponge for miR-29b and miR-497-5p, and a potential regulator of Wnt, PI3K, and TGFB signaling pathways in breast carcinoma.
Norouzi R; Mohamadzade Z; Norouzi R; Norouzi R; Esmaeili R; Soltani BM
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1972. PubMed ID: 38225865
[TBL] [Abstract] [Full Text] [Related]
2. RSK3 switches cell fate: from stress-induced senescence to malignant progression.
Huna A; Flaman JM; Lodillinsky C; Zhu K; Makulyte G; Pakulska V; Coute Y; Ruisseaux C; Saintigny P; Hernandez-Vargas H; Defossez PA; Boissan M; Martin N; Bernard D
J Exp Clin Cancer Res; 2023 Nov; 42(1):318. PubMed ID: 38008756
[TBL] [Abstract] [Full Text] [Related]
3. An NFATc1/smad3/cJUN Complex Restricted to smad4-Deficient Pancreatic cancer Guides Rational Therapies.
Hasselluhn MC; Schlösser D; Versemann L; Schmidt GE; Ulisse M; Oschwald J; Zhang Z; Hamdan F; Xiao H; Kopp W; Spitalieri J; Kellner C; Schneider C; Reutlinger K; Nagarajan S; Steuber B; Sastra SA; Palermo CF; Appelhans J; Bohnenberger H; Todorovic J; Kostyuchek I; Ströbel P; Bockelmann A; König A; Ammer-Herrmenau C; Schmidleitner L; Kaulfuß S; Wollnik B; Hahn SA; Neesse A; Singh SK; Bastians H; Reichert M; Sax U; Olive KP; Johnsen SA; Schneider G; Ellenrieder V; Hessmann E
Gastroenterology; 2024 Feb; 166(2):298-312.e14. PubMed ID: 37913894
[TBL] [Abstract] [Full Text] [Related]
4. The multifaceted mechanisms of ellagic acid in the treatment of tumors: State-of-the-art.
Lu G; Wang X; Cheng M; Wang S; Ma K
Biomed Pharmacother; 2023 Sep; 165():115132. PubMed ID: 37423169
[TBL] [Abstract] [Full Text] [Related]
5. Mutational signatures for breast cancer diagnosis using artificial intelligence.
Odhiambo P; Okello H; Wakaanya A; Wekesa C; Okoth P
J Egypt Natl Canc Inst; 2023 May; 35(1):14. PubMed ID: 37184779
[TBL] [Abstract] [Full Text] [Related]
6. Effective inhibition of breast cancer stem cell properties by quercetin-loaded solid lipid nanoparticles via reduction of smad2/smad3 phosphorylation and β-catenin signaling pathway in triple-negative breast cancer.
Hatami M; Kouchak M; Kheirollah A; Khorsandi L; Rashidi M
Biochem Biophys Res Commun; 2023 Jul; 664():69-76. PubMed ID: 37141640
[TBL] [Abstract] [Full Text] [Related]
7. Pleckstrin-2-promoted PPM1B degradation plays an important role in transforming growth factor-β-induced breast cancer cell invasion and metastasis.
Du L; Li J; Tian Y; Feng R
Cancer Sci; 2023 Jun; 114(6):2429-2444. PubMed ID: 36928924
[TBL] [Abstract] [Full Text] [Related]
8. TGF-β1/smad3 upregulates UCA1 to promote liver fibrosis through DKK1 and miR18a.
Yang Z; Zhang H; Yin M; Cheng Z; Jiang P; Feng M; Liu Z; Liao B
J Mol Med (Berl); 2022 Oct; 100(10):1465-1478. PubMed ID: 36001113
[TBL] [Abstract] [Full Text] [Related]
9. FA-HA-Amygdalin@Fe
Abdel-Rafei MK; Askar MA; Azab KS; El-Sayyad GS; El Kodous MA; El Fatih NM; Tawill GE; Thabet NM
Curr Cancer Drug Targets; 2023; 23(2):118-144. PubMed ID: 35975846
[TBL] [Abstract] [Full Text] [Related]
10. RNA
Tan B; Zhou K; Liu W; Prince E; Qing Y; Li Y; Han L; Qin X; Su R; Pokharel SP; Yang L; Zhao Z; Shen C; Li W; Chen Z; Zhang Z; Deng X; Small A; Wang K; Leung K; Chen CW; Shen B; Chen J
Theranostics; 2022; 12(13):5727-5743. PubMed ID: 35966596
[TBL] [Abstract] [Full Text] [Related]
11. Uncarboxylated osteocalcin promotes proliferation and metastasis of MDA-MB-231 cells through TGF-β/smad3 signaling pathway.
Xu J; Ma L; Wang D; Yang J
BMC Mol Cell Biol; 2022 Apr; 23(1):18. PubMed ID: 35413833
[TBL] [Abstract] [Full Text] [Related]
12. Synthesis and structure-activity relationship study of a potent MHO7 analogue as potential anti-triple negative breast cancer agent.
Liang JJ; Yu WL; Yang L; Qin KM; Yin YP; Li D; Ni YH; Yan JJ; Zhong YX; Deng ZX; Hong K
Eur J Med Chem; 2022 Jun; 236():114313. PubMed ID: 35390712
[TBL] [Abstract] [Full Text] [Related]
13. HLF regulates ferroptosis, development and chemoresistance of triple-negative breast cancer by activating tumor cell-macrophage crosstalk.
Li H; Yang P; Wang J; Zhang J; Ma Q; Jiang Y; Wu Y; Han T; Xiang D
J Hematol Oncol; 2022 Jan; 15(1):2. PubMed ID: 34991659
[TBL] [Abstract] [Full Text] [Related]
14. PolyI:C attenuates transforming growth factor-β signaling to induce cytostasis of surrounding cells by secreted factors in triple-negative breast cancer.
Tamura Y; Tsutsumi S; Miyazono K; Koinuma D
Cancer Sci; 2022 Mar; 113(3):940-949. PubMed ID: 34897916
[TBL] [Abstract] [Full Text] [Related]
15. Epigenetic regulation of triple negative breast cancer (TNBC) by TGF-β signaling.
Vishnubalaji R; Alajez NM
Sci Rep; 2021 Jul; 11(1):15410. PubMed ID: 34326372
[TBL] [Abstract] [Full Text] [Related]
16. Resveratrol Enhances Inhibition Effects of Cisplatin on Cell Migration and Invasion and Tumor Growth in breast cancer MDA-MB-231 Cell Models In Vivo and In Vitro.
Yang MD; Sun Y; Zhou WJ; Xie XZ; Zhou QM; Lu YY; Su SB
Molecules; 2021 Apr; 26(8):. PubMed ID: 33921192
[TBL] [Abstract] [Full Text] [Related]
17. MMP11 promotes the proliferation and progression of breast cancer through stabilizing smad2 protein.
Zhuang Y; Li X; Zhan P; Pi G; Wen G
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649832
[TBL] [Abstract] [Full Text] [Related]
18. EEF1A2 interacts with HSP90AB1 to promote lung adenocarcinoma metastasis via enhancing TGF-β/smad signalling.
Jia L; Ge X; Du C; Chen L; Zhou Y; Xiong W; Xiang J; Li G; Xiao G; Fang L; Li Z
Br J Cancer; 2021 Mar; 124(7):1301-1311. PubMed ID: 33473168
[TBL] [Abstract] [Full Text] [Related]
19. Anti-pyroptotic function of TGF-β is suppressed by a synthetic dsRNA analogue in triple negative breast cancer cells.
Tamura Y; Morikawa M; Tanabe R; Miyazono K; Koinuma D
Mol Oncol; 2021 May; 15(5):1289-1307. PubMed ID: 33342034
[TBL] [Abstract] [Full Text] [Related]
20. SIPA1 enhances smad2/3 expression to maintain stem cell features in breast cancer cells.
Wang N; Weng J; Xia J; Zhu Y; Chen Q; Hu D; Zhang X; Sun R; Feng J; Minato N; Gong Y; Su L
Stem Cell Res; 2020 Dec; 49():102099. PubMed ID: 33296812
[TBL] [Abstract] [Full Text] [Related]
[Next]
